tlooto
Sign up
SCIESCOPUSQ1

JOURNAL OF PSYCHOPHARMACOLOGY

SAGE PUBLICATIONS LTD, United Kingdom

JOURNAL OF PSYCHOPHARMACOLOGY is an academic journal published by SAGE PUBLICATIONS LTD (United Kingdom). Identifiers: ISSN 0269-8811, eISSN 1461-7285. Indexed in SCIE, SCOPUS. Metrics: JIF 5.5, CiteScore 9.9, SJR 1.708, SNIP 1.37. Subject areas: CLINICAL NEUROLOGY, NEUROSCIENCES, PHARMACOLOGY & PHARMACY, PSYCHIATRY. tlooto lists 4,466 papers from this journal.

CiteScore

9.90

Scopus citation metric

SJR

1.708

SCImago rank

SNIP

1.37

Source normalized impact

Percentage rank

-

JIF percentile rank

Journal profile

ISSN
0269-8811
eISSN
1461-7285
Abbreviation
J PSYCHOPHARMACOL
Publisher
SAGE PUBLICATIONS LTD
Country
United Kingdom

Web of Science categories

SCIECLINICAL NEUROLOGY, NEUROSCIENCES, PHARMACOLOGY & PHARMACY, PSYCHIATRY

Scopus ASJC categories

2736 Pharmacology (medical)2738 Psychiatry and Mental Health3004 Pharmacology

Keywords

Clinical Neurology | Neurosciences | Pharmacology & Pharmacy | Psychiatry

Papers in this journal

Recent papers

  1. Ten practical suggestions for setting up a psychedelic study.

    2026

  2. Cardiovascular mortality and depression: A systematic review and meta-analysis of the association with antidepressant treatment and co-morbidity

    2026

  3. Clozapine-induced neutropenia: Prevalence and associated factors.

    2026

  4. Drug harms in Canada: A multi-criteria decision analysis

    2026 · 1 citations

  5. α5-GABAA allosteric modulation triggers and prolongs dopamine neuronal activity via AMPA receptors

    2026

Most cited papers

  1. Human Hallucinogen Research: Guidelines for Safety

    2008 · 1,036 citations

  2. Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

    2015 · 1,024 citations

  3. 5-HT and mechanisms of defence

    1991 · 964 citations

  4. Evidence-based guidelines for treating bipolar disorder: revised third edition Recommendations from the British Association for Psychopharmacology

    2009 · 944 citations

  5. Pilot Study of the 5-HT2AR Agonist Psilocybin in the Treatment of Tobacco Addiction

    2014 · 837 citations